One 30-year-old patient with a family history of BC (HT163B1) has a germline frameshift variant of unknown significance (p.Y1672fs) in BRCA2 that has significant loss of heterozygosity in the tumor (FDR = 0.0001). The gene discussed is BRCA2; the disease is neoplasm.